Oral delivery of group A streptococcal cell walls augments circulating TGF-β and suppresses streptococcal cell wall arthritis

Journal of Immunology

Volumn 161, Issue 11, 1998, Pages 6297-6304

  Chen, Wanjun ^a   Jin, Wenwen ^a   Cook, Melissa ^a   Weiner, Howard L ^b   Wahl, Sharon M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; PEPTIDOGLYCAN POLYSACCHARIDE; STREPTOCOCCUS ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL ARTHRITIS; BACTERIAL CELL WALL; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY INFILTRATE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPLEEN LYMPHOCYTE; STREPTOCOCCUS GROUP A;

ACUTE DISEASE; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ARTHRITIS; CELL MOVEMENT; CELL WALL; CHRONIC DISEASE; CYTOKINES; FEMALE; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; LYMPHOID TISSUE; PEPTIDOGLYCAN; RATS; RATS, INBRED LEW; SPLEEN; STREPTOCOCCUS PYOGENES; SYNOVITIS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0032403567     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hines, K. L., M. Christ, and S. M. Wahl. 1993. Cytokine regulation of the immune response: an in vivo model. Immunomethods 3:13.
2. Brandes, M. E., J. B. Allen, Y. Ogawa, and S. M. Wahl. 1991. Transforming growth factor β1 suppresses acute and chronic arthritis in experimental animals. J. Exp. Med. 87:1108.
3. Allen, J. B., D. G. Malone, S. M. Wahl, G. B. Calandra, and R. L. Wilder. 1985. Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. J. Clin. Invest. 76:1042.
4. McCartney-Francis, N., J. B. Allen, D. E. Mizel, J. E. Albina, Q. Xie, C. F. Nathan, and S. M. Wahl. 1993. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:749.
5. Wahl, S. M., J. B. Allen, K. Ohura, D. E. Chenoweth, and A. R. Hand. 1991. IFN-γ inhibits inflammatory cell recruitment and the evolution of bacterial cell wall-induced arthritis. J. Immunol. 146:95.
6. Allen, J. B., H. L. Wong, G. L. Costa, M. J. Bienkwski, and S. M. Wahl. 1993. Suppression of monocyte function and differential regulation of IL-1 and IL-1rα by IL-4 contribute to resolution of experimental arthritis. J. Immunol. 151:4344.
7. Weiner, H. L. 1997. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18:335.
8. Strober, W., B. Kelsall, and T. Marth. 1998. Oral tolerance. J. Clin. Immunol. 18:1.
9. Nussenblatt, R., R. Caspi, R. Mahdi, C. Chan, F. Roberge, O. Lider, and H. Weiner. 1989. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance by S-antigen. J. Immunol. 144:1689.
10. Nagler-Anderson, C., C. A. Bober, M. Robinson, G. Siskind, and G. Thorbecke. 1983. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. USA 83:7443.
11. Zhang, Z. J., L. E. Davidson, G. Eisenbarth, and H. L. Weiner. 1991. Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88:10252.
12. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
13. Whitacre, C. C., I. E. Gienapp, C. G. Orosz, and D. M. Bitar. 1991. Oral tolerance in experimental autoimmune encephalomyelitis III. evidence for clonal anergy. J. Immunol. 147:2155.
14. Chen, Y., J. Inobe, R. Marks, P. Gonnella, V. K. Kuchroo, and H. L. Weiner. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177.
15. Wahl, S. M., D. A. Hunt, H. L. Wong, S. Dougherty, N. McCartney-Francis, L. M. Wahl, L. Ellingsworth, J. A. Schmidt, G. Hall, A. B. Roberts, et al. 1988. Transforming growth factor-β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol. 140:3026.
16. Kalden, J. R., and J. Sieper. 1998. Oral collagen in the treatment of rheumatoid arthritis. Arthritis Rheum. 41:191.
17. Barnett, M. L., J. M. Kremer, E. M. Clair, D. O. Clegg, D. Furst, M. Weisman, M. J. Fletcher, S. Chasan-Taber, E. Finger, A. Morales, et al. 1998. Treatment of rheumatoid arthritis with oral type II collagen, results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 41:290.
18. Postlethwaite, A. E., A. H. Kang, and L. K. Myers. 1997. NSAIDs abrogate oral tolerance induction to type II collagen in DBA/1 mice. Arthritis Rheum. 40:S54 (Abstr.).
19. Wahl, S. M., J. B. Allen, G. L. Costa, H. L. Wong, and J. R. Dasch. 1993. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor-β. J. Exp. Med. 177:225.
20. Khoury, S. J., W. W. Hancock, and H. L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential up-regulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
21. + T cells. J. Exp. Med 184:19.
22. + T-cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 389:737.
23. + T lymphocytes. J. Immunol. 142:748.
24. Feldmann, M., and F. M. Brennan. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397.
25. Brennan, F. M., and M. Feldmann. 1996. Cytokines in autoimmunity. Curr. Opin. Immunol. 8:872.
26. Marth, T., W. Strober, R. A. Seder, and B. L. Kelsall. 1997. Regulation of transforming growth factor-β production by interleukin-12. Eur J. Immunol. 27:1213.
27. Wahl, S. M. 1994. Transforming growth factor: the good, the bad, and the ugly. J. Exp. Med. 180:1587.
28. Song, X., M. Gu, W. Jin, D. Klinman, and S. M. Wahl. 1998. Plasmid DNA encoding transforming growth factor-β1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J. Clin. Invest. 101:2615.
29. Tsunawaki, S., M. Sporn, A. Ding, and C. Nathan. 1988. Deactivation of macrophages by transforming growth factor-β. Nature 334:260.
30. Gamble, J. R., Y. Khew-Goodall, and M. A. Vadas. 1993. Transforming growth factor-β inhibits E-selectin expression on human endothelial cells. J. Immunol. 150:4494.
31. Buelens, C., F. Willems, A. Delvanx, G. Pierard, J. P. Delville, T. Velu, and M. Goldman. 1995. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol. 25:2668.
32. O'Garra, A. 1995. Interleukin-10: an inhibitor of macrophage-dependent stimulation of Th1 cells. In Interleukin-10. R. de Waal Malefyt and J. E. de Vries, ed. R. G. Landes Co., Houston, p. 69.
33. + T cells to secrete IL-4. Adv. Exp. Med. Biol. 417:375.